Universe Pharmaceuticals Inc.
Organization details
- Legal name
- Universe Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- China
- Headquarters city
- Ji'an, Jiangxi
- Headquarters country
- China
- Fiscal year end
- September
- Ticker symbol
- UPC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001809616
Board of directors
-
Ding Zheng · DirectorSince 2026
-
Gang Lai · Director · Chief Executive OfficerSince 2026
-
Jiawen Pang · DirectorSince 2026
-
Lin (Lydia) Yang · Director · Chief Financial OfficerSince 2026
-
Yongping Yu · DirectorSince 2026
Chief executives
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Universe Pharmaceuticals Inc.
Who is the CEO of Universe Pharmaceuticals Inc.?
Gang Lai has been Universe Pharmaceuticals Inc.'s Chief Executive Officer since March 2026.
How many directors are on Universe Pharmaceuticals Inc.'s board?
Universe Pharmaceuticals Inc.'s board has 5 directors: Ding Zheng, Gang Lai, Jiawen Pang, Lin (Lydia) Yang and Yongping Yu.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="universe-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.